Справочник Пользователя для Microsoft Corporation RM-200

Under the law, FDA does not review the safety of radiation-emitting 
consumer products such as wireless phones before they can be sold, as it 
does with new drugs or medical devices. However, the agency has 
authority to take action if wireless phones are shown to emit 
radiofrequency energy (RF) at a level that is hazardous to the user. In 
such a case, FDA could require the manufacturers of wireless phones to 
notify users of the health hazard and to repair, replace or recall the 
phones so that the hazard no longer exists.

Although the existing scientific data do not justify FDA regulatory 
actions, FDA has urged the wireless phone industry to take a number of 
steps, including the following:

• Support needed research into possible biological effects of RF of the 

type emitted by wireless phones; 

• Design wireless phones in a way that minimizes any RF exposure to 

the user that is not necessary for device function; and 

• Cooperate in providing users of wireless phones with the best 

possible information on possible effects of wireless phone use on 
human health.

FDA belongs to an interagency working group of the federal agencies 
that have responsibility for different aspects of RF safety to ensure 
coordinated efforts at the federal level. The following agencies belong 
to this working group:

• National Institute for Occupational Safety and Health

• Environmental Protection Agency

• Federal Communications Commission

• Occupational Safety and Health Administration

• National Telecommunications and Information Administration

The National Institutes of Health participates in some interagency 
working group activities, as well.

FDA shares regulatory responsibilities for wireless phones with the 
Federal Communications Commission (FCC). All phones that are sold in 
the United States must comply with FCC safety guidelines that limit RF